Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7934757 | 0.88 | ALDH1A1 (0.40) | ALDH1A1POLBMAPTSERPINE1HTT | |
| SCHEMBL10632584 | 0.84 | HTT (0.35) | ALDH1A1SERPINE1HTTGRIN2DGRIN3B | |
| SCHEMBL13917721 | 0.83 | SERPINE1 (0.31) | SERPINE1HTTGRIN2DGRIN3BGRIN1 | |
| SCHEMBL15933348 | 0.82 | ALDH1A1 (0.37) | ALDH1A1POLBMAPTSERPINE1HTT | |
| SCHEMBL27373566 | 0.82 | PRKCA (0.34) | ALDH1A1POLBMAPTPRKCA | |
| SCHEMBL6881130 | 0.82 | — | — | |
| SCHEMBL9489545 | 0.81 | HTT (0.33) | SERPINE1HTT | |
| SCHEMBL954672 | 0.80 | MMP8 (0.38) | ALDH1A1POLBMAPTSERPINE1HTT | |
| SCHEMBL11758824 | 0.80 | ALDH1A1 (0.37) | ALDH1A1POLBMAPTSERPINE1HTT | |
| SCHEMBL15894726 | 0.80 | KDM4E (0.40) | ALDH1A1POLBMAPTSERPINE1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112142565-B | Neopentyl glycol refining and ester removing method and device system with low energy consumption | 万华化学集团股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-112142565-A | Neopentyl glycol refining and ester removing method and device system with low energy consumption | 万华化学集团股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| US-6818049-B1 | HALOGEN FREE INDUSTRIAL SOLVENT FORMULATION; LOW REACTIVITY TO OZONE FORMATION | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-11-16 | — | — | US | claimed |
| US-6506243-B1 | Industrial solvents; dialkyl carbonates, alkyl acetates, dioxolanes, pivalates, isobutyrates, nitriles | EXXONMOBIL CHEMICAL PATENTS INC. | 2003-01-14 | — | — | US | claimed |
| WO-2002064687-A1 | ENVIRONMENTALLY PREFERRED FLUIDS AND FLUID BLENDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-08-22 | — | — | WO | claimed |
| EP-1090085-A1 | ENVIRONMENTALLY PREFERRED FLUIDS AND FLUID BLENDS | EXXON CHEMICAL PATENTS INC. (US) | 2001-04-11 | — | — | EP | claimed |
| WO-1999057217-A1 | ENVIRONMENTALLY PREFERRED FLUIDS AND FLUID BLENDS | EXXON CHEMICAL PATENTS INC. (US) | 1999-11-11 | — | — | WO | claimed |
| WO-2025228965-A1 | SINTERING AID | ILIKA TECHNOLOGIES LTD (GB) | 2025-11-06 | — | — | WO | disclosed |
| US-12122737-B2 | Method for continuously producing diols from aldehydes by means of Raney cobalt catalysis | OQ CHEMICALS GMBH (DE) | 2024-10-22 | — | — | US | disclosed |
| US-20240347687-A1 | COMPONENT FOR USE IN AN ENERGY STORAGE DEVICE OR AN ENERGY CONVERSION DEVICE AND METHOD FOR THE MANUFACTURE THEREOF | ILIKA TECHNOLOGIES LTD (GB) | 2024-10-17 | — | — | US | disclosed |
| EP-4331022-A1 | COMPONENT FOR USE IN AN ENERGY STORAGE DEVICE OR AN ENERGY CONVERSION DEVICE AND METHOD FOR THE MANUFACTURE THEREOF | Ilika Technologies Limited (GB) | 2024-03-06 | — | — | EP | disclosed |
| CN-117486703-A | Preparation method of 2, 4-tetramethyl-1, 3-cyclobutanedione | 万华化学集团股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| EP-3747855-B1 | METHOD FOR THE CONTINUOUS PREPARATION OF DIOLS FROM ALDEHYDES USING RANEY-COBALT CATALYSIS | OQ CHEMICALS GMBH (DE) | 2024-01-10 | — | — | EP | disclosed |
| US-5041621-A | Process for the preparation of dihydroxy esters | EASTMAN KODAK COMPANY (US) | 1991-08-20 | — | — | US | disclosed |
| WO-1991004960-A1 | PROCESS FOR THE PREPARATION OF DIHIDROXY ESTERS | EASTMAN KODAK COMPANY (US) | 1991-04-18 | — | — | WO | disclosed |
| EP-0420770-A1 | Process for the preparation of dihydroxy esters | EASTMAN CHEMICAL COMPANY (US) | 1991-04-03 | — | — | EP | disclosed |
| EP-0284912-A2 | Elastomers containing polyamide and polyurea groups and procedure for the preparation of elastic, compact or cellular mouldings thereof | BASF Aktiengesellschaft (DE) | 1988-10-05 | — | — | EP | disclosed |
| US-4225726-A | Catalytic condensation of aldehydes to 1,3-glycol monoesters | EASTMAN KODAK COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
| US-4021496-A | Process for the purification of neopentyl glycol | EASTMAN KODAK COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
| US-3939216-A | CONTINUOUS, MULTISTAGE, FROM ISOBUTYRALDEHYDE AND FORMALDEHYDE | EASTMAN KODAK COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12122737-B2 | Method for continuously producing diols from aldehydes by means of Raney cobalt catalysis | C9, ADH1C, HAO2 | ALDH1A1 120/4885POLB 303/4885MAPT 2962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.